跳至主要内容
临床试验/NCT06328062
NCT06328062招募中不适用

Comparison Efficacy of Mirogabalin and Pregabalin in Total Knee Arthroplasty. a Randomized Controlled Trial

Thammasat University Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
80
试验地点
1
主要终点
Pain score

研究概览

简要总结

The goal of this RCT is to compare efficacy between mirogabalin and pregabalin in pain reducing after unilateral primary total knee arthroplasty.

The main question[s] it aims to answer are:

• Does mirogabalin have better pain reduction than pregabalin after unilateral primary total knee arthroplasty.

Participants will randomized to mirogabalin or pregabalin group and will take the drug for 2 weeks after TKA. Researchers will compare to pregabalin group to see pain and functional outcomes after TKA.

详细描述

After surgery is complete, you will be randomly assigned to receive painkillers Mirogabalin or Pregabalin along with other standard medications.

Surgery by Mirogabalin group: Participants received 5 mg of mirogabalin, one tablet taken twice a day, after breakfast and dinner, for 2 weeks.

In the pregabalin group: Participants received 75 mg of pregabalin, one tablet taken daily before bedtime, for 2 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 50-85 years old
  • •Unilateral primary osteoarthritis undergoing primary TKA

排除标准

  • •GFR <60
  • •Allergy to drug in this study
  • •Cannot underwent spinal anesthesia and adductor canal block
  • •Taking gabapentinoid within 3 months before surgery
  • •History of previous knee surgery
  • •Severe liver disease

研究组 & 干预措施

Pregabalin

Active Comparator

Participants will receive 75 mg of pregabalin, once a day before bedtime, for 2 weeks.

干预措施: Pregabalin (Drug)

Mirogabalin

Experimental

Participants will receive 5 mg of mirogabalin, twice a day, after breakfast and dinner, for 2 weeks.

干预措施: Mirogabalin (Drug)

结局指标

主要结局

Pain score

时间窗: Every 6 hours after surgery for 2 days, then twice a day for 2 weeks, then once a week until 12 week after surgery.

Visual analog scale at rest and motion (0-100 points, 0 mean best, 100 mean worst)

次要结局

  • Morphine consumption(72 hours after surgery)
  • Sedation score(24 hour, 48 hour, 2 week, 6 week and 12 week after surgery)
  • Range of motion(24 hour, 48 hour, 2 week, 6 week and 12 week after surgery)
  • Knee society score(2 week, 6 week and 12 week after surgery)
  • Incidence of Somnolence and dizziness(everyday until 14 days then once a week until 12 weeks after surgery)
  • Total hospital stay(up to 1 week)
  • Knee injury and Osteoarthritis Outcome Score (KOOS)(2 week, 6 week and 12 week after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yot Tanariyakul

Principle investigator

Thammasat University Hospital

研究点 (1)

Loading locations...

相似试验